P. C. Waldmeier
Impact in
- Cellular and Molecular Neuroscience top 0.5%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 68
- Neuroscience and Neuropharmacology Research 51
-
- Tryptophan and brain disorders 8
- Co-authors
- L. MaîtreJ.-J. FeldtrauerA. Delini‐StulaJohn J. LemastersP. A. BaumannAlexander G. RabchevskyJoe E. SpringerPatrick G. Sullivan
- Journals
- Naunyn-Schmiedeberg s Archives of Pharmacology (22 papers)European Journal of Pharmacology (18 papers)Biochemical Pharmacology (10 papers)Journal of Neural Transmission (9 papers)Pharmacopsychiatry (6 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
P. C. Waldmeier
149 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 123
- Cellular and Molecular Neuroscience 2.8k
- Biological Psychiatry 229
- Neurology 890
- Psychiatry and Mental health 608
- Toxicology 123
Countries citing papers authored by P. C. Waldmeier
This map shows the geographic impact of P. C. Waldmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. C. Waldmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. C. Waldmeier more than expected).
Fields of papers citing papers by P. C. Waldmeier
This network shows the impact of papers produced by P. C. Waldmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. C. Waldmeier. The network helps show where P. C. Waldmeier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. C. Waldmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 0 | |
| 2 | 2007 | 43 | |
| 3 | 2003 | 152 | |
| 4 | 2003 | 80 | |
| 5 | 2001 | 13 | |
| 6 | Neurorescuing effects of the GAPDH ligand CGP 3466B | 2000 | 8 |
| 7 | 1998 | 17 | |
| 8 | 1994 | 2 | |
| 9 | 1994 | 82 | |
| 10 | 1993 | 12 | |
| 11 | 1993 | 6 | |
| 12 | 1991 | 43 | |
| 13 | 1991 | 4 | |
| 14 | 1990 | 19 | |
| 15 | 1990 | 13 | |
| 16 | 1990 | 8 | |
| 17 | 1990 | 11 | |
| 18 | 1989 | 14 | |
| 19 | 1988 | 5 | |
| 20 | Interaction of alpha-agonists and -antagonists with dopaminergic transmission | 1981 | 2 |
About P. C. Waldmeier
P. C. Waldmeier is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry, Equine, Neurology and Psychiatry and Mental health, having authored 155 papers that have together received 5.2k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (68 papers), Neuroscience and Neuropharmacology Research (51 papers), Receptor Mechanisms and Signaling (29 papers), Parkinson's Disease Mechanisms and Treatments (16 papers), Treatment of Major Depression (10 papers), Tryptophan and brain disorders (8 papers), Schizophrenia research and treatment (7 papers) and Mitochondrial Function and Pathology (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.8k citations), Biological Psychiatry (229 citations), Neurology (890 citations), Psychiatry and Mental health (608 citations) and Toxicology (123 citations). P. C. Waldmeier has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include L. Maître, J.-J. Feldtrauer, A. Delini‐Stula, John J. Lemasters, P. A. Baumann, Alexander G. Rabchevsky, Joe E. Springer, Patrick G. Sullivan, Kaspar Zimmermann and Peter Baumann. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, European Journal of Pharmacology, Biochemical Pharmacology, Journal of Neural Transmission and Pharmacopsychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.